Soleil Securities Initiates Coverage on Sequenom (SQNM) with a Buy, Top Pick in Med-Tech
Tweet Send to a Friend
Soleil Securities initiates coverage on Sequenom (Nasdaq: SQNM) with a Buy. Price target $26.
Soleil analyst says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Soleil analyst says, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
